89bio_May_2022_901_83901

Loading viewer...

investor_presentation

Format: PDF investor_presentation

This investor presentation by 89bio Inc discusses forward-looking statements regarding their product candidates and clinical trials, focusing on pegozafermin.

Browse all investor_presentations →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from 89bio Inc

View all →

investor_presentation

report

Similar investor_presentations from other companies

Browse all →

Tejas Networks Q1 FY24 Investor Presentation 2023

investor_presentation

9 Pages

Tejas Networks Limited

Wejo Limited Investor Presentation 2023

investor_presentation